Study of MK-0472 in Participants with Advanced/Metastatic Solid Tumors (MK-0472-001)

Trial Identifier: 0472-001
Sponsor: MSD
Start Date: July 2023
Primary Completion Date: February 2028
Study Completion Date: February 2028
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary – English

Trial Locations

Country Location
Canada, ON Toronto, ON, Canada, M5G 2M9
Canada, QC Montréal, QC, Canada, H2X 0A9
Switzerland, Geneve Genève, Geneve, Switzerland, 1211
Switzerland, Sankt Gallen St.Gallen, Sankt Gallen, Switzerland, 9007
Switzerland, Ticino Bellinzona, Ticino, Switzerland, 6500
United States, IL Chicago, IL, United States, 60611
United States, NJ Hackensack, NJ, United States, 07601